EcoDrugPlus

Proteasome 20s Subunit Alpha 6b

Ensembl ID : ENSAPEG00000015590
Gene Symbol: PSMA6B
1 Cross references
262 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSAPEG00000005737
Gene Symbol: PSMA8
1 Cross references
183 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSAPEG00000005813
Gene Symbol: PSMB1
2 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSAPEG00000005490
Gene Symbol: PSMB1
2 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSAPEG00000014042
Gene Symbol: PSMB10
1 Cross references
172 Possible Orthologues:

Proteasome 20s Subunit Beta 11b

Ensembl ID : ENSAPEG00000017005
Gene Symbol: PSMB11B
1 Cross references
161 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSAPEG00000022265
Gene Symbol: PSMB2
1 Cross references
219 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSAPEG00000013173
Gene Symbol: PSMB3
1 Cross references
261 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSAPEG00000003592
Gene Symbol: PSMB4
1 Cross references
215 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSAPEG00000019669
Gene Symbol: PSMB5
1 Cross references
223 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSAPEG00000020960
Gene Symbol: PSMB6
1 Cross references
228 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSAPEG00000014128
Gene Symbol: PSMB7
1 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).